Literature DB >> 9612372

VEGF and bFGF stimulate myocardial vascularization in embryonic chick.

R J Tomanek1, K Lotun, E B Clark, P R Suvarna, N Hu.   

Abstract

We tested the hypothesis that early vascularization of the embryonic heart is enhanced after bolus injections of vascular, endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) into the vitelline vein before the onset of myocardial vasculogenesis (3.5 days, stage 21). Electron and light microscopy were utilized to obtain morphometric data. At stages 29 and 31, myocardial vessel volume or numerical density were higher in embryos injected with 50 ng bFGF than in the saline-injected controls. A VEGF injection increased vascular volume density at stage 29 and both volume and numerical, density at stage 31, bFGF, but not VEGF, was associated with an enhancement of the sinusoidal system (spongy layer of the ventricle) at stage 29. This effect disappeared by stage 31. In conclusion, 1) enhancement of bFGF or VEGF before myocardial vascularization increases vascular growth, but the initial effect of bFGF is greater; 2) the effects of these growth factors on vascular volume and numerical density are temporally dependent; and 3) bFGF, in addition to its effects on the coronary vasculature, influences ventricular modeling by apparently acting on myocytes as well as endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9612372     DOI: 10.1152/ajpheart.1998.274.5.H1620

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

Review 1.  Vascularized bone tissue engineering: approaches for potential improvement.

Authors:  Lonnissa H Nguyen; Nasim Annabi; Mehdi Nikkhah; Hojae Bae; Loïc Binan; Sangwon Park; Yunqing Kang; Yunzhi Yang; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2012-09-04       Impact factor: 6.389

Review 2.  Role of growth factors in coronary morphogenesis.

Authors:  Robert J Tomanek; Wei Zheng
Journal:  Tex Heart Inst J       Date:  2002

Review 3.  Coronary artery anomalies. Part I: Recent insights from molecular embryology.

Authors:  Y von Kodolitsch; W D Ito; O Franzen; G K Lund; D H Koschyk; T Meinertz
Journal:  Z Kardiol       Date:  2004-12

4.  Embryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells.

Authors:  Robert J Tomanek; Lance P Christensen; Michael Simons; Masahiro Murakami; Wei Zheng; Gina C Schatteman
Journal:  Dev Dyn       Date:  2010-12       Impact factor: 3.780

5.  The growth promoting effects of bFGF, PD-ECGF and VEGF on cultured postimplantation rat embryos deprived of serum fractions.

Authors:  H Ulger; A K Karabulut; M K Pratten
Journal:  J Anat       Date:  2000-08       Impact factor: 2.610

Review 6.  Hypoxia and fetal heart development.

Authors:  A J Patterson; L Zhang
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

7.  FGFR-1 is required by epicardium-derived cells for myocardial invasion and correct coronary vascular lineage differentiation.

Authors:  David J Pennisi; Takashi Mikawa
Journal:  Dev Biol       Date:  2009-01-27       Impact factor: 3.582

8.  Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor.

Authors:  Monica M Montano; Yong Qui Doughman; Huayun Deng; Laura Chaplin; Jianqi Yang; Nancy Wang; Qiang Zhou; Nicole L Ward; Michiko Watanabe
Journal:  Circ Res       Date:  2007-12-13       Impact factor: 17.367

9.  Vascular endothelial growth factor and the collateral circulation: the story continues.

Authors:  William M Chilian; Yuh Fen Pung
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

10.  Coronary endothelial proliferation and morphogenesis are regulated by a VEGF-mediated pathway.

Authors:  Tresa L Nesbitt; Andrea Roberts; Hong Tan; Lorain Junor; Michael J Yost; Jay D Potts; Robert W Dettman; Richard L Goodwin
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.